Clinical trial Recruiting at 1 site Observational Ages 18 to 65

Vitamin D and LL-37 Levels in Peri-Implant Fluids

Official title: Evaluation of 25(OH)D3 and LL-37 Levels in Peri-implant Sulcus Fluid in Peri-implant Diseases

Run by Recep Tayyip Erdogan University · NCT07280754 · Data updated 2026-11-12

This study tests whether levels of vitamin D in peri-implant fluids and the antimicrobial peptide LL-37 differ in people with dental implants who have mucositis or peri-implantitis.

More Peri-implantitis trials

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment72 (estimated)
SponsorRecep Tayyip Erdogan University
Academic / other
Locations1 site (Rize, Islampasa Street)
StatusRecruiting
StartedDecember 30, 2025
Main results expectedJune 1, 2027
Study endsJune 1, 2027
Registry record updatedNovember 3, 2026
Trial IDNCT07280754 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with at least one dental implant for one year, and no recent antibiotic/anti-inflammatory therapy or periodontal/peri-implant treatment in the prior six months.

Probably not a fit

Individuals with systemic conditions or lifestyle factors that affect peri-implant status or those taking vitamin D supplements may not directly benefit from this observational analysis.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will measure 25(OH)D3 and LL-37 levels in peri-implant sulcus fluid from adults with dental implants. It aims to describe how these markers relate to peri-implant health status and inflammatory cytokines. No active intervention is planned; data will be analyzed to explore potential associations with implant conditions and local inflammatory processes. The study leverages a single-site setting to collect biological samples and clinical information from eligible participants. Results may inform future research on vitamin D–related pathways in peri-implant disease.

Why it matters

Potential benefit: If relationships are found, this work could guide future strategies for prevention or management of peri-implant diseases through vitamin D–related pathways.

How similar studies have gone: Other studies have explored cytokines and biomarkers in peri-implant fluids, but this study is among the first to examine LL-37 and 25(OH)D3 in peri-implant sulcus fluid together.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Being between the ages of 18-65,
* Having dental implants and using implant-supported prostheses for at least one year,
* Not having used systemic and/or topical antibiotics/anti-inflammatory drugs or mouthwashes in the last three months,
* Not having received periodontal/peri-implant treatment in the last six months.

Exclusion Criteria:

* Having a systemic disease or condition that affects peri-implant status,
* Having a metabolic bone disease,
* Bruxism,
* Being pregnant or lactating,
* Having received periodontal/peri-implant treatment within the last 6 months,
* Smoking and alcohol use,
* Taking vitamin D supplements.

Where it's running

  • Recep Tayyip Erdoğan University
    Rize, Islampasa Street, Turkey (Türkiye)
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.